440 related articles for article (PubMed ID: 31842894)
1. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
2. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
5. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.
Riccio EK; Totino PR; Pratt-Riccio LR; Ennes-Vidal V; Soares IS; Rodrigues MM; de Souza JM; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2013 Sep; 12():326. PubMed ID: 24041406
[TBL] [Abstract][Full Text] [Related]
7. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon.
Furini AA; Capobianco MP; Storti-Melo LM; Cunha MG; Cassiano GC; Machado RL
Malar J; 2016 Jul; 15(1):374. PubMed ID: 27435973
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity.
Morais CG; Soares IS; Carvalho LH; Fontes CJ; Krettli AU; Braga EM
Am J Trop Med Hyg; 2006 Oct; 75(4):582-7. PubMed ID: 17038677
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection.
Múfalo BC; Gentil F; Bargieri DY; Costa FT; Rodrigues MM; Soares IS
Microbes Infect; 2008 Oct; 10(12-13):1266-73. PubMed ID: 18692152
[TBL] [Abstract][Full Text] [Related]
13. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
[TBL] [Abstract][Full Text] [Related]
15. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
[TBL] [Abstract][Full Text] [Related]
16. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
Labadie-Bracho MY; van Genderen FT; Adhin MR
Malar J; 2020 Oct; 19(1):360. PubMed ID: 33032606
[TBL] [Abstract][Full Text] [Related]
17. Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.
Soares RR; Nakaie CR; Rodrigues-da-Silva RN; da Silva RL; Lima-Junior JDC; Scopel KKG
Parasite Immunol; 2020 May; 42(5):e12705. PubMed ID: 32096238
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
Bitencourt AR; Vicentin EC; Jimenez MC; Ricci R; Leite JA; Costa FT; Ferreira LC; Russell B; Nosten F; Rénia L; Galinski MR; Barnwell JW; Rodrigues MM; Soares IS
PLoS One; 2013; 8(2):e56061. PubMed ID: 23457498
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.
Sepúlveda N; Morais CG; Mourão LC; Freire MF; Fontes CJ; Lacerda MV; Drakeley CJ; Braga ÉM
Malar J; 2016 Nov; 15(1):559. PubMed ID: 27852258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
